alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

RAYMOND A. ROLES,

Plaintiff

- Appellant,

v.

JAY CHRISTENSEN, ISCC Warden;

RHONDA OWENS, ISCC, ASM,

Defendants

- Appellees. No. 20

- 35071

D.C. No. 1:19

- cv

- 00292

- DCN

MEMORANDUM *

Appeal from the United States District Court

for the District of Idaho

David C. Nye, District Judge, Presiding

Submitted December 2 , 2020 * *

Before: WALLACE, CLIFTON, and BRESS, Circuit Judges.

Idaho state prisoner Raymond A. Roles appeals pro se from the district

court’s judgment dismissing his action brought under 42 U.S.C. § 1983 and the

Religious Land Use and Institutionalized Persons Act (“RLUIPA”). We have

jurisdiction under 28 U.S.C. § 12 91. We review de novo. Watison v. Carter , 668

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

DEC 10 2020

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS2 20

- 35071

F.3d 1108, 1112 (9th Cir. 2012) ( dismissal under 28 U.S.C. § 1915(e)(2)(B)(ii)) ;

Resnick v. Hayes , 213 F.3d 443, 447 (9 th Cir. 2000) ( dismissal under 28 U.S.C.

§ 1915A)

. W e affirm.

The district court properl y dismissed Roles’s action because Roles failed to

allege facts sufficient to show that defendants’ conduct placed a substantial burden

on his religious exercise. See Jones v. Williams , 791 F.3d 1023, 1031

- 32 (9th Cir.

2015) (elements of § 1983 free exerc ise claim); Walker v. Beard , 789 F.3d 1125,

1134 (9th Cir. 2015) (elements of a RLUIPA claim); San Jose Christian Coll. v.

City of Morgan Hill , 360 F.3d 1024, 1034 (9th Cir. 2004) (under RLUIPA, to

constitute a substantial burden on religious exercise, a regulation “must impose a

significantly great restriction or onus upon such exercise”).

AFFIRMED.
I 

118TH CONGRESS 

2D SESSION H. R. 7466 

To amend the Legislative Reorganization Act of 1946 to reduce the rates 

of pay of Members of Congress during a fiscal year if Congress has 

not agreed to a concurrent resolution on the budget for such fiscal 

year, to repeal the automatic appropriation of funds for the salaries 

of Members of Congress, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 28, 2024 

Mr. BURCHETT introduced the following bill; which was referred to the Committee on House Administration, and in addition to the Committee on 

Oversight and Accountability, for a period to be subsequently determined 

by the Speaker, in each case for consideration of such provisions as fall 

within the jurisdiction of the committee concerned 

A BILL 

To amend the Legislative Reorganization Act of 1946 to 

reduce the rates of pay of Members of Congress during 

a fiscal year if Congress has not agreed to a concurrent 

resolution on the budget for such fiscal year, to repeal 

the automatic appropriation of funds for the salaries 

of Members of Congress, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Do Your Job Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7466 IH

1 SEC. 2. REDUCTION IN RATES OF PAY FOR MEMBERS OF 

2 CONGRESS FOR FAILURE TO AGREE TO 

3 BUDGET RESOLUTION. 

4 (a) REDUCTION.—Section 601(a)(2) of the Legisla5 tive Reorganization Act of 1946 (2 U.S.C. 4501(2)) is 

6 amended to read as follows: 

7 ‘‘(2) If, by the first day of a fiscal year, both Houses 

8 of Congress have not agreed to a concurrent resolution 

9 on the budget pursuant to section 301 of the Congres10 sional Budget Act of 1974 for such fiscal year, the annual 

11 rate of pay for each of the positions described in para12 graph (1) for pay periods occurring during such fiscal year 

13 shall be equal to 90 percent of the annual rate of pay for 

14 such position for the most recent pay period preceding 

15 such fiscal year.’’. 

16 (b) EFFECTIVE DATE.—The amendment made by 

17 subsection (a) shall apply with respect to pay periods oc18 curring after the date of the regularly scheduled general 

19 election for Federal office held in November 2024. 

20 SEC. 3. REPEAL OF AUTOMATIC APPROPRIATION OF SALA21 RIES OF MEMBERS OF CONGRESS. 

22 (a) REPEAL.—Effective with respect to each fiscal 

23 year beginning on or after the date of the enactment of 

24 this Act, section 130(c) of Public Law 97–51 (2 U.S.C. 

25 4502) is repealed. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7466 IH

1 (b) CONFORMING AMENDMENT.—Section 601(a)(1) 

2 of the Legislative Reorganization Act of 1946 (2 U.S.C. 

3 4501(1)) is amended by striking ‘‘The annual rate of pay’’ 

4 and inserting ‘‘Subject to the availability of appropria5 tions, the annual rate of pay’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Exhibit 32



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION
1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Solely
in connection with the filing of the Annual Report of Retractable Technologies, Inc. (the Company) on Form 10-KSB for the period ended December 31, 2004, as filed with the United States Securities and Exchange Commission on the date
hereof (the Report), the undersigned Thomas J. Shaw, Chief Executive Officer, and Douglas W. Cowan, Chief Financial Officer, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:



(1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report as of the dates and for the periods covered by the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



March 31, 2005



/s/ THOMAS J. SHAWTHOMAS J. SHAWPRESIDENT, CHAIRMAN, ANDCHIEF EXECUTIVE OFFICER/s/ DOUGLAS W. COWANDOUGLAS W. COWANVICE PRESIDENT ANDCHIEF FINANCIAL OFFICER
FORM 10-Q/A

Securities and Exchange Commission

Washington, D.C.  20549

(Mark One)

[**X**]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:  **September 30, 2003**
[   ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 

SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________.

Commission File No. 0-22372.
**GRAND TOYS INTERNATIONAL, INC.**
(Exact Name of Registrant as Specified in its Charter)	
**Nevada                                         		       **98-0163743                                                   
(State or other jurisdiction of			      (I.R.S. Employer

incorporation or organization	     Identification No.)
**1710 Route Transcanadienne, Dorval, Quebec, Canada, H9P 1H7**
(Address of principal executive offices)
**(514) 685-2180**
(Registrant's telephone number, including Area Code)

(Former name, former address and former fiscal year, 

if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
****
Yes	**X**		No    _____

Indicate the number of shares outstanding of each of the Issuer's classes of common equity, as of November 14, 2003: 2,835,244
** 
**GRAND TOYS INTERNATIONAL, INC.
 
Index to Quarterly Report on Form 10 - Q/A
Filed with the Securities and Exchange Commission**Period ended September 30, 2003
 **ITEMS IN FORM 10 - Q/A**PAGE**Part I - Financial Information

Item 1.  Consolidated Financial Statements:  
Consolidated Balance Sheets 
At September 30, 2003 and December 31, 2002
2-3  
Consolidated Statements of Operations 
For the three Month and Nine Month Periods ended September 30, 2003 and 2002
4  
Consolidated Statements of Stockholders' Equity and Comprehensive Income  
For the Nine Month Period ended September 30, 2003 
5  
Consolidated Statements of Cash Flows 
For the Nine Month Period ended September 30, 2003 and 2002
6  
Notes to Consolidated Financial Statements
7-19  
Item 2.  Management's Discussion and Analysis of Financial Condition 
and  Results of Operations
20-30
Item 3. Quantitative and Qualitative Disclosures About Market Risks
30
Item 4.  Controls and Procedures
30-31**Part II - Other Information   
Item 1.  Legal proceedings
31
Item 2.  Changes in Securities and Use of Proceeds
31
Item 3.  Defaults Upon Senior Securities
31
Item 4.  Submission of Matters to a Vote of Security Holders
31
Item 5.  Other Information
31
Item 6.  Exhibits and Reports on Form 8-K
31-32 
Signatures
33-34  
Certifications
38-41******************
39049.

#### DIXIE CONSTRUCTION COMPANY OF GEORGIA, INC. v. GRIFFIN.

Felton, Chief Judge.

1. The purpose of the provision of the law relating to the giving of ten days’ notice to the debtor of the creditor’s intention to enforce the provision for attorney’s fees in a contract is to allow the debtor to pay the principal and interest on the contract within ten days from receipt of the notice and relieve himself of the liability to pay attorney’s fees. *Code*§ 20-506 (c) as amended. The fact that the notice states that the contract provides for 15% attorney’s fees instead of 10% as actually provided for in the contract does not destroy the efficacy of the notice for the simple reason that only the amount provided in the contract under 15% could be recovered and compliance with the notice would absolve the debtor of the obligation to pay the fees whatever the percentage was. The court did not err in overruling the special demurrer directed at the sufficiency of the notice to bind for attorney’s fees.

2. Subsection (b) of the act of 1953 (Ga. L. 1953, Jan.-Feb. Sess., p. 545; *Code Ann.*§ 20-506 (b)) only limits the amount which may be allowed as attorney’s fees under contract provisions to 15% and this section does not mean that 15% may be recovered where the provision for such fees in a contract is for less than 15%.

*458Decided September 27, 1961.

*Hitch, Miller & Beckmann, R. N. Hitch,*for plaintiff in error.

*Willis J. Richardson, Jr., Myrick, Myrick ■& Richardson,*contra.

Accordingly, it was error for the court to -enter judgment for 15% of the principal and interest due instead of for 10% as stipulated in the note sued on.

The trial court’s judgments are affirmed with the direction that the court write off 5% of the amount of the principal and interest allowed for attorney’s fees.

*Judgments affirmed with direction.*

*Bell and Hall, JJ., concur.*
I 

118TH CONGRESS 

1ST SESSION H. R. 764 

To require the Secretary of the Interior to reissue regulations removing 

the gray wolf from the list of endangered and threatened wildlife under 

the Endangered Species Act of 1973. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2023 

Mrs. BOEBERT (for herself, Mr. TIFFANY, Mr. BERGMAN, Mr. BIGGS, Mr. 

GALLAGHER, Mr. LAMALFA, Mr. MOYLAN, Mr. NEHLS, Mr. NEWHOUSE, 

Mr. OGLES, Mr. PERRY, Mr. ROSENDALE, Mr. STAUBER, Mr. ZINKE, Mr. 

GROTHMAN, Mr. GOSAR, Mr. CRANE, Mr. VAN ORDEN, Mr. STEIL, Mr. 

FITZGERALD, Mrs. FISCHBACH, Mr. BUCK, and Mr. MOOLENAAR) introduced the following bill; which was referred to the Committee on Natural 

Resources 

A BILL 

To require the Secretary of the Interior to reissue regulations 

removing the gray wolf from the list of endangered and 

threatened wildlife under the Endangered Species Act 

of 1973. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Trust the Science 

5 Act’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 764 IH

1 SEC. 2. REMOVING THE GRAY WOLF FROM THE LIST OF EN2 DANGERED AND THREATENED WILDLIFE. 

3 Not later than 60 days after the date of enactment 

4 of this section, the Secretary of the Interior shall reissue 

5 the final rule entitled ‘‘Endangered and Threatened Wild6 life and Plants; Removing the Gray Wolf (Canis lupus) 

7 From the List of Endangered and Threatened Wildlife’’ 

8 and published on November 3, 2020 (85 Fed. Reg. 

9 69778). 

10 SEC. 3. NO JUDICIAL REVIEW. 

11 Reissuance of the final rule under section 2 shall not 

12 be subject to judicial review. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
```

[115th Congress Public Law 285]
[From the U.S. Government Publishing Office]

[[Page 132 STAT. 4369]]

Public Law 115-285
115th Congress

                                 An Act

 
To designate the facility of the United States Postal Service located at 
  390 West 5th Street in San Bernardino, California, as the ``Jack H. 
                      Brown Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. JACK H. BROWN POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 390 West 5th Street in San Bernardino, California, shall be 
known and designated as the ``Jack H. Brown Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Jack H. 
Brown Post Office Building''.

    Approved December 6, 2018.

LEGISLATIVE HISTORY--H.R. 2979:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 164 (2018):
            July 16, considered and passed House.
            Nov. 15, considered and passed Senate.

                                  <all>
```
# C_2014372EN.01002301.xml

| 20.10.2014 | EN | Official Journal of the European Union | C 372/23 |
| --- | --- | --- | --- |

20.10.2014

EN

Official Journal of the European Union

C 372/23

---

Order of the General Court of 3 September 2014 — ANKO v Commission and REA

(Case T-165/14) (1)

1

2014/C 372/29

Language of the case: Greek

The President of the Third Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 175, 10.6.2014.

1

---
[Federal Register Volume 75, Number 40 (Tuesday, March 2, 2010)]
[Notices]
[Page 9423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4288]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Impact of Japanese Encephalitis Vaccination in 
Cambodia, Funding Opportunity Announcement (FOA) CK10-003, Initial 
Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12 p.m.-2 p.m., May 3, 2010 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Impact of Japanese Encephalitis Vaccination in 
Cambodia, FOA CK10-003.''
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-2293.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 24, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-4288 Filed 3-1-10; 8:45 am]
BILLING CODE 4163-18-P
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000814070
<NAME> DRY DIARY INTERNATIONAL, INC.
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          21,702
<SECURITIES>                                         0
<RECEIVABLES>                                  162,484
<ALLOWANCES>                                         0
<INVENTORY>                                    113,596
<CURRENT-ASSETS>                               309,226
<PP&E>                                         660,845
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 970,071
<CURRENT-LIABILITIES>                          137,399
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     2,423,093
<OTHER-SE>                                 (1,811,710)
<TOTAL-LIABILITY-AND-EQUITY>                   970,071
<SALES>                                        497,192
<TOTAL-REVENUES>                               497,192
<CGS>                                          397,334
<TOTAL-COSTS>                                  378,201
<OTHER-EXPENSES>                                 5,153
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,900
<INCOME-PRETAX>                              (275,396)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (275,396)
<EPS-PRIMARY>                                   (0.00)
<EPS-DILUTED>                                   (0.00)
        

</TABLE>
Exhibit








Exhibit 10.3


Director Compensation Summary
We currently pay our non-management directors an annual retainer of $265,000 per year, $120,000 of which is paid in cash and $145,000 of which is paid in restricted stock. A director may elect to receive his or her entire annual retainer (plus the additional annual retainer amounts described below) in restricted stock.
Restricted stock vests on the day immediately prior to the first annual general meeting of shareholders at which directors are elected following the grant of the stock. However, if, prior to such vesting date, either (i) a change in control (as defined in the Assured Guaranty Ltd. 2004 Long-Term Incentive Plan, as amended) of Assured Guaranty Ltd. occurs before the director terminates service on the Board or (ii) the director terminates service on the Board as a result of such director’s death or disability, then the restricted stock will vest on the date of such change in control or the date of the director’s termination of service, whichever is applicable. Grants of restricted stock receive cash dividends and have voting rights.
Our Share Ownership Guidelines require that each director own the greater of (i) at least 25,000 Common Shares or (ii) Common Shares with a market value of at least five times the maximum cash portion of the annual director retainer (which is currently 5 x $120,000 = $600,000), before being permitted to dispose of any shares acquired as compensation from the Company. Once a director has reached the Share Ownership Guideline, for so long as he or she serves on the Board, such director may not dispose of any Common Shares if such disposition would cause the director to be below the Share Ownership Guideline. Vested restricted stock, vested restricted stock units (i.e., units for which Common Shares will be received by a director six months after termination of such director’s service on the Board), and purchased shares will all count toward the Stock Ownership Guideline.
In addition to the annual retainer described above:
		
	•
	The Chairman of the Board receives an additional $225,000 annual retainer


		
	•
	The Chairman of each of the Audit Committee, the Compensation Committee, the Finance Committee, the Nominating and Governance Committee, and the Risk Oversight Committee, receives an additional $30,000 annual retainer


		
	•
	Members, other than the chairman of the committee or the Chairman of the Board, of each of the Audit Committee, the Compensation Committee, the Finance Committee, the Nominating and Governance Committee (unless also the Chairman of the Board) and the Risk Oversight Committee receive an additional $15,000 annual retainer.


Members of the Executive Committee do not receive any additional compensation.
The Company generally will not pay a fee for attendance at board or committee meetings, although the Chairman of the Board has the discretion to pay attendance fees of $2,000 for extraordinary or special meetings.


May 2017
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of ViroPharma Incorporated (the Company) on Form
10-K for the period ending December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                                         
|-------------------------------------------------------------------------
|/s/ Vincent J. Milano                                                    
|Vincent J. Milano                                                        
|President, Chief Executive Officer and Chairman of the Board of Directors
|February 27, 2009                                                        



|                                       
|---------------------------------------
|/s/ Charles A. Rowland, Jr.            
|Charles A. Rowland, Jr.                
|Vice President, Chief Financial Officer
|February 27, 2009
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1385 17-Hydroxycorticosteroids (17-ketogenic steroids) test system. ( a ) *Identification.* A 17-hydroxycorticosteroids (17-ketogenic steroids) test system is a device intended to measure corticosteroids that possess a dihydroxyacetone moiety on the steroid nucleus in urine. Corticosteroids with this chemical configuration include cortisol, cortisone 11-desoxycortisol, desoxycorticosterone, and their tetrahydroderivatives. This group of hormones is synthesized by the adrenal gland. Measurements of 17-hydroxycorticosteroids (17-ketogenic steroids) are used in the diagnosis and treatment of various diseases of the adrenal or pituitary glands and gonadal disorders.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987; 52 FR 29468, Aug. 7, 1987, as amended at 65 FR 2306, Jan. 14, 2000]